• von Willebrand Factor Activity (Ristocetin Cofactor)
  • Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
  • LiquidHALLMARK Multi Cancer Panel
  • Hepatic Function Panel (Liver Panel)
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • DNA Cell Cycle Analysis by Flow Cytometry
  • MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors
  • Comprehensive Pharmacogenetics (PGx) Gene Variation Panel
  • Hemophilia A (F8) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

Turnaround Time
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.
Loading...